Circulative biomarkers as predictors of cardiovascular events in patients after treatment of Hodgkin lymphoma
Aim. Nature development of lymphoma associates with increased risk of cardiovascular diseases. We aimed to evaluate the prognostic value of circulating NT-proBNP, galectin-3, and VE-cadherin in survivors of Hodgkin lymphoma. Methods: Surveys were given to Hodgkin lymphoma survivors who reached at...
Saved in:
| Main Author: | B. B. Samura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2017-12-01
|
| Series: | Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki |
| Subjects: | |
| Online Access: | http://pharmed.zsmu.edu.ua/article/view/113558/110369 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Value of circulating N-terminal pro-brain natriuretic peptide for prognosis of cardiovascular events in patients with non-Hodgkin lymphoma in remission
by: B. B. Samura
Published: (2015-12-01) -
Predictive value of circulating N-terminal pro-brain natriuretic peptide in patients after treatment of Hodgkin lymphoma (a 3-year prospective study)
by: B. B. Samura
Published: (2017-12-01) -
Lower NT‐proBNP plasma concentrations in Pacific peoples with heart failure
by: Andree G. Pearson, et al.
Published: (2025-08-01) -
Cardiac biomarkers for screening and prognostication of cardiac dysfunction in critically ill patients
by: Oscar Cavefors, et al.
Published: (2024-12-01) -
The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure
by: Yanxiang Sun, et al.
Published: (2025-08-01)